ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/bde6e3b5230fa2440eabd951de583806.pdf

Abstract Title

First Name *

Jonathan

Last Name *

Barratt

Co-author 1

Bart Maes bart.maes@azdelta.be AZ Delta Nephrology Roeselare

Co-author 2

Rubeen Israni rubeen.israni@veratx.com Vera Therapeutics Clinical Development Brisbane

Co-author 3

Xuelian Wei xuelian.wei@veratx.com Vera Therapeutics Biostatistics Brisbane

Co-author 4

Jürgen Floege jfloege@ukaachen.de RWTH Aachen University Nephrology Aachen

Co-author 5

Vivekanand Jha vjha@georgeinstitute.org.in The George Institute for Global Health India Nephrology New Delhi

Co-author 6

Vladimir Tesar vladimir.tesar@vfn.cz Charles University Nephrology Prague

Co-author 7

Hong Zhang hongzh@bjmu.edu.cn Peking University First Hospital Renal Beijing

Co-author 8

Sean Barbour sean.barbour@vch.ca University of British Columbia Nephrology Vancouver

Co-author 9

Hitoshi Suzuki shitoshi@juntendo.ac.jp Juntendo University Faculty of Medicine Nephrology Tokyo

Co-author 10

Hernan Trimarchi htrimarchi@hotmail.com Hospital Británico de Buenos Aires Nephrology Buenos Aires

Co-author 11

Celia Lin celia.lin@veratx.com Vera Therapeutics Medical Brisbane

Co-author 12

Richard Lafayette czar@stanford.edu Stanford University Nephrology Stanford

Co-author 13

Co-author 14

Co-author 15

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos